Scholars Central

Brief reportPublished Feb 2012

Study shows that abatacept is ALLOWed to be withdrawn in patients with rheumatoid arthritis

Authors: Bulletin Board

Welcome to the Journal

Volume 7 · Issue 1 · Pages 7

More from this journal

The newest in Welcome to the Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalWelcome to the Journal
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Bulletin Board”